Navigation Links
Lightwave Logic, Inc. Announces the Addition of Anthony J. Cocuzza, PhD to its Technology Team
Date:2/19/2009

NEWARK, Del., Feb. 19 /PRNewswire-FirstCall/ -- Lightwave Logic, Inc. (OTC Bulletin Board: LWLG - News; http://lightwavelogic.com), a technology company focused on the development of electro-optic polymer materials for applications in high speed fiber-optic telecommunications and optical computing, announced today the addition of Anthony J. Cocuzza, PhD to our technology team. Dr. Cocuzza worked for 30 years in medicinal chemistry and brings a highly developed set of synthetic and analytical skills to Lightwave Logic.

A graduate of Princeton, Dr. Cocuzza spent 24 years with DuPont engaged in R&D in corporate R&D and with DuPont's joint venture with Merck. He retired in 2008 from Bristol-Meyers Squib. Cocuzza has contributed to programs in many areas of medicinal and biological chemistry. David Eaton, CTO of Lightwave commented: "We are extremely happy to attract a scientist with Dr. Cocuzza's talents. His capabilities are an excellent match to our needs. We expect he will be able to contribute strongly to our efforts to expand our molecular materials base."

Jim Marcelli, CEO of Lightwave stated, "I'm very excited to have Dr. Cocuzza join the Lightwave family. Tony's experience in organic synthesis will help to streamline our preparation and scale-up of our Perkinamine family of materials."

About Lightwave Logic, Inc.

Lightwave Logic, Inc. is a development stage company, moving toward prototype demonstration and commercialization of its high-activity, high-stability organic polymers for applications in electro-optical device markets. Electro-optical devices convert data from electric signals into optical signals for use in high-speed fiber-optic telecommunications systems and optical computers. Please visit the Company's website, www.lightwavelogic.com, for
'/>"/>

SOURCE Lightwave Logic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hologic, Inc. to Host Investor Reception at the RSNA Trade Show
2. ETEX Launches Innovative Osteoinductive Orthobiologic, EquivaBone(TM)
3. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
4. Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens
5. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
6. Psychemedics Corporation Announces 2008 Year End Results
7. BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
8. Amicus Therapeutics Announces Change to Board of Directors
9. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast
10. Obio Pharmaceutical Announces Product Growth Strategy
11. Pressure BioSciences, Inc. Announces Completion of Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 The National ... in Muncie IN, is pleased to announce that it ... National Museum of the United States Air Force. , ... year-long process that concluded this spring with an on-site ... Dayton, OH museum. , The National Museum of ...
(Date:7/25/2014)... 2014 "Ischemic Stroke and Cerebral ... data on the Ischemic Stroke and Cerebral Stroke ... and data relating to the clinical trials on ... global Ischemic Stroke Research Report 2014 at: ... the trial numbers and their recruitment status as ...
(Date:7/25/2014)... -- Trillions of bacteria live in each person,s digestive ... digest food and stave off harmful infections, but their ... To help shed light on the role of these ... professor Eric Alm recently tracked fluctuations in the bacterial ... The findings, described in the July 25 issue of ...
(Date:7/25/2014)... 25, 2014 Research and Markets ... Metabolomics Market 2014-2018" report to their offering. ... Metabolomics or Metabonomics is the scientific study ... a new experimental technique that is being widely ... Metabolites are small molecules that are present in ...
Breaking Biology Technology:AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2
... THE WOODLANDS, Texas, Oct. 4 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... Ph.D., Lexicon,s president and chief executive officer, will present,at ... Francisco, California,on Thursday, October 11, 2007 at 11:00 a.m. ... may be accessed on its,corporate website at http://www.lexpharma.com ...
... Oct. 4 Genzyme Corp.,(Nasdaq: GENZ ) ... market,Elaprase(R) (idursulfase) in Japan for the treatment of ... by Shire Human Genetic,Therapies Inc., and Genzyme is ... countries under an agreement with Shire. Genzyme intends,to ...
... CLARA, Calif., Oct. 4 Coherent, Inc.,(Nasdaq: COHR ... 2007, it,received an additional NASDAQ Staff Determination letter indicating ... listing,requirements as set forth in Marketplace Rules 4350(e) and ... of stockholders during its fiscal,year ended September 30, 2007. ...
Cached Biology Technology:Lexicon Pharmaceuticals to Present at Bio InvestorForum 2Genzyme Receives Approval to Market Elaprase(R) in Japan 2Genzyme Receives Approval to Market Elaprase(R) in Japan 3Genzyme Receives Approval to Market Elaprase(R) in Japan 4Coherent, Inc. Receives Expected Letter from NASDAQ 2
(Date:7/28/2014)... for Biologically Inspired Engineering at Harvard University today ... commercialized by a newly formed private company to ... medicine products. The announcement follows a ... Development (OTD) and the start-up Emulate Inc., relating ... Organs-on-Chips platform. , "This is a big ...
(Date:7/27/2014)... nicotine and cotinine, a metabolite of nicotine, can potentially ... smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or NNK is produced ... up in the tobacco smoke. Once inhaled, it is ... activated by a variety of enzymes called Cytochrome P450 ... can partially interfere with the activation of NNK, and ...
(Date:7/27/2014)... mayfly in the southern Western Ghats, a mountain range along ... first time that any mayfly belonging to the genus ... new species, called Labiobaetis soldani , "is named in ... the understanding of the Ephemeroptera of Palaearctic and Oriental realms," ... new mayfly in the Journal of Insect Science . ...
Breaking Biology News(10 mins):Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... senior female family members should play a key role in ... societies. However, they are often overlooked by health organisations that ... as an obstacle to promoting good nutrition and health practices. ... review published in the January issue of Maternal and ...
... This press release is available in German . ... as tsunamis, landslides, and ground settlements, caused a damage of ... the so far highest economic losses due to earthquakes. This ... from the Center for Disaster Management and Risk Reduction Technology ...
... Springer celebrates its 50,000th eBook, available on ... milestone underscores Springer,s position as the largest eBook ... world,s most comprehensive online collection of science, technology ... In addition, as announced in October 2011, ...
Cached Biology News:Research highlights key role grandmothers play in mother and child nutrition and health 2Research highlights key role grandmothers play in mother and child nutrition and health 3Japan and New Zealand were hit hardest by earthquakes 2SpringerLink now offers more than 50,000 eBooks 2
... The Mini-PROTEAN 3 Dodeca cell with multi-casting ... of up to 12 mini format handcast (8.3 ... cm) gels. The cell requires 3.4-4.4 L of ... cooling coil that attaches to an external refrigerated ...
...
... has been developed to significantly increase the ... Stability is increased at room temperature ... This product is subjected to 0.2 ... azide. This formulation insures consistently high ...
...
Biology Products: